Methotrexate-resistance develops in approximately one-third of low-risk GTN patients.
Subsequent use of single-agent dactinomycin or carboplatin results in an 80–90% complete hCG response rate.
Multi-agent chemotherapy, associated with greater toxicity, can be reserved for sequential single-agent chemotherapy failure.
Overall survival should approximate 100%.